文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年慢病共病管理

任何剂量的中高强度身体活动均可降低全因痴呆风险,且不受衰弱状态影响

Moderate-to-Vigorous Physical Activity at any Dose Reduces All-Cause Dementia Risk Regardless of Frailty Status.
PubMed 文献 · J Am Med Dir Assoc · 2025-01-28

该研究基于英国生物银行中89,667名佩戴腕部加速度计的痴呆风险成人(中位年龄63岁,56%女性),平均随访4.4年共735人发生痴呆。结果显示每周MVPA每增加30分钟,全因痴呆风险降低4%(HR 0.96,95%CI 0.93-0.99);与0分钟/周相比,各活动剂量组风险均显著降低,且衰弱状态无显著交互作用。

要点

  • 每周MVPA每增加30分钟,全因痴呆风险降低4%(HR 0.96,95%CI 0.93-0.99)。
  • 与0分钟/周相比,每周0-34.9、35-69.9、70-139.9及≥140分钟MVPA组痴呆风险均显著降低。

核心结论

  • 任何额外剂量的中高强度身体活动均可降低痴呆风险,尤其在不进行MVPA的个体中获益最大。
  • 衰弱状态未显著改变MVPA与全因痴呆风险之间的关联。

研究设计与样本

  • 前瞻性队列研究中的生存分析,数据来自英国生物银行。
  • 纳入89,667名有全因痴呆风险且于2013年2月至2015年12月佩戴Axivity AX3三轴腕部加速度计的成人(中位年龄63岁,56%女性)。
  • 采用改良版身体衰弱表型定义衰弱,使用Cox回归模型分析MVPA剂量与首次痴呆发病的关联。

主要发现

  • 平均随访4.4年,735名参与者发生痴呆。
  • 平均每周MVPA为126分钟。
  • 每周MVPA每增加30分钟,全因痴呆风险降低4%(HR 0.96,95%CI 0.93-0.99)。

关键数值与推荐

  • MVPA推荐量为每周150分钟,但老年人尤其衰弱者难以达到。

临床怎么用

  • 对痴呆风险老年人,应鼓励任何剂量的MVPA,而非仅追求每周150分钟推荐量。
  • 不进行MVPA的个体增加活动量可能获益最大。
  • 衰弱状态不应作为限制MVPA推荐的理由。

局限性

  • 平均随访4.4年相对较短,痴呆事件数有限。
  • MVPA通过腕部加速度计估计,可能存在测量误差。
  • 研究为观察性设计,无法完全排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Reaching the moderate-to-vigorous physical activity (MVPA) recommendations of 150 min/wk is difficult for older adults, particularly among those living with frailty and its associated risk of dementia. We examined the dose-response relationship between MVPA and dementia risk among at-risk persons living with and without frailty enrolled in the UK Biobank study. DESIGN: Survival analysis within a prospective cohort study. SETTINGS AND PARTICIPANTS: Participants at risk for all-cause dementia who wore an Axivity AX3 triaxial wrist-worn accelerometer between February 2013 and December 2015. METHODS: MVPA was estimated from wrist-worn accelerometry in a subpopulation of the UK Biobank study. A modified version of the physical frailty phenotype was used to define frailty. Associations between MVPA dose (including interactions with frailty) and first-time incident dementia were analyzed using Cox regression models. MVPA was treated continuously and categorically across 5 levels to estimate the dose-response curve. Models were adjusted for demographics, frailty status, and comorbidities. RESULTS: This study included 89,667 adults (median age, 63 years; 56% women), with 735 participants developing dementia over an average of 4.4 years. Average weekly MVPA was 126 minutes. Each 30 minutes higher MVPA was associated with a 4% reduction in the risk of all-cause dementia (hazard ratio, 0.96; 95% CI, 0.93-0.99). The hazard ratios for engaging in 0-34.9, 35-69.9, 70-139.9, and ≥140 MVPA minutes per week were 0.59, 0.40, 0.37, and 0.31, respectively (P < .05 for all) compared with 0 MVPA minutes per week. All associations were similar across frailty status (interaction P for all models > .21). CONCLUSIONS AND IMPLICATIONS: Our results suggest engaging in any additional amount of MVPA reduces dementia risk, with the highest benefit appearing among individuals with no MVPA. These associations are not substantially modified by frailty status.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Wanigatunga AA, Dong Y, Jin M, et al. Moderate-to-Vigorous Physical Activity at any Dose Reduces All-Cause Dementia Risk Regardless of Frailty Status. J Am Med Dir Assoc. 2025. PMID: 39826907. doi:10.1016/j.jamda.2024.105456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。